Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population

Xiaolong Zhu; Runzhi Huang; Peng Hu; Penghui Yan; Suna Zhai; Jie Zhang; Junwei Zhuang; Huabin Yin; Tong Meng; Daoke Yang; Zongqiang Huang

doi:10.12659/MSM.929154

17 February 2021 : Database Analysis

Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population

Xiaolong Zhu^1BCDEF, Runzhi Huang^12ABCDEF, Peng Hu^1E, Penghui Yan^1ABCDEF, Suna Zhai^3D, Jie Zhang^2AE, Junwei Zhuang^1F, Huabin Yin^4E, Tong Meng^4AF*, Daoke Yang^3F, Zongqiang Huang^1AG

DOI: 10.12659/MSM.929154

Med Sci Monit 2021; 27:e929154

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions Supplementary Data References

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Hematoxylin and eosin (HE) slides and gross specimens of patients in the validation dataset with a histopathological diagnosis of malignant giant cell tumor of bone.

Back to the Article

Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population

Your Privacy